Intraperitoneal gene delivery mediated by a novel cationic liposome in a peritoneal disseminated ovarian cancer model

Gene Therapy

Volumn 9, Issue 13, 2002, Pages 859-866

  Lee, M J ^a   Cho, S S ^a   You, J R ^b   Lee, Y ^a   Kang, B D ^a   Choi, J S ^a   Park, J W ^b   Suh, Y L ^b   Kim, J A ^b   Kim, D K ^b   Park, J S ^a  

^a Seoul National University   (South Korea)

^b Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Intraperitoneal gene delivery; O Chol; Ovarian cancer; Peritoneal disseminated cancer model

Indexed keywords

3BETA[1 ORNITHINAMIDECARBAMOYL]CHOLESTEROL; BETA GALACTOSIDASE; CHLORAMPHENICOL ACETYLTRANSFERASE; DNA; LIPOFECTAMINE; LIPOFECTIN; LIPOSOME; LUCIFERASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER MODEL; COMPLEX FORMATION; CONTROLLED STUDY; DRUG EFFICACY; DRUG SELECTIVITY; DRUG SENSITIVITY; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; NONVIRAL GENE THERAPY; OVARY CANCER; PERITONEUM CANCER; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REPORTER GENE;

ANIMALS; BETA-GALACTOSIDASE; FEMALE; GENE THERAPY; GENETIC VECTORS; HUMANS; INJECTIONS, INTRAPERITONEAL; LIPOSOMES; LUCIFERASES; MICE; MICE, NUDE; OVARIAN NEOPLASMS; PERITONEAL NEOPLASMS; PHOSPHATIDYLETHANOLAMINES; RETROVIRIDAE; TRANSFECTION; TUMOR CELLS, CULTURED;

ANIMALIA; FALLOPIA; FELIS CATUS; MUS MUSCULUS;

EID: 0036290424     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3301704     Document Type: Article

References (39)

1. Intraperitoneal chemotherapy in ovarian cancer
2. An advanced generation of adenoviral vectors selectively enhances gene transfer for ovarian cancer gene therapy approaches
3. How cancer arises
4. Gene therapy for cancer
5. Ex vivo and in vivo gene transfer to the peritoneal membrane in a rat model
6. Combined suicide and cytokine gene therapy for peritoneal carcinomatosis
7. Intraperitoneal delivery of hrR3 and ganciclovir prolongs survival in mice with disseminated pancreatic cancer
8. Differential expression of cytokine genes in monocytes, peritoneal macrophages and liver following endotoxin- or turpentine-induced inflammation in rat
9. In utero delivery of adeno-associated viral vectors: Intraperitoneal gene transfer produces long-term expression
10. Gene therapy for primary and metastatic pancreatic cancer with intraperitoneal retroviral vector bearing the wild-type p53 gene
11. Adenoviral-mediated suicide gene therapy for ovarian cancer
12. Intraperitoneal gene therapy with adenoviral-mediated p53 tumor suppressor gene for ovarian cancer model in nude mouse
13. Murine retroviral vector producer cells survival and toxicity in the peritoneal cavity of dogs
14. Therapy of peritoneal carcinomatosis from colon cancer with oncolytic adenoviruses
15. Neutralisation of adenovirus infectivity by ascitic fluid from ovarian cancer patients
16. Adenoviral-mediated delivery of herpes simplex virus thymidine kinase results in tumor reduction and prolonged survival in a SCID mouse model of human ovarian carcinoma
17. Effect of preexisting anti-herpes immunity on the efficacy of herpes simplex viral therapy in a murine intraperitoneal tumor model
18. Intracavitary liposome-mediated p53 gene transfer into glioblastoma with endogenous wild-type p53 in vivo results in tumor suppression and long-term survival
19. Development of novel cationic liposomes for efficient gene transfer into peritoneal disseminated tumor
20. In vivo transfer of bacterial marker genes results in differing levels of gene expression and tumor progression in immunocompetent and immunodeficient mice
21. Soluble Flt-1 gene therapy for peritoneal metastases using HVJ-cationic liposomes
22. Development of biomaterials for gene therapy
23. Nonviral vectors in the new millennium: Delivery barriers in gene transfer
24. Nonviral gene therapy: Promises and challenges
25. New cationic liposomes for gene transfer into mammalian cells with high efficiency and low toxicity
26. Overcoming the inhibitory effect of serum on lipofection by increasing the charge ratio of cationic liposome to DNA
27. Dynamic changes in the characteristics of cationic lipidic vectors after exposure to mouse serum: Implications for intravenous lipofection
28. N-Palmitoylphosphatidylethanolamine stabilizes liposomes in the presence of human serum: Effect of lipidic composition and system characterization
29. Improved cationic lipid formulations for in vivo gene therapy
30. Liposome and polylysine mediated gene therapy
31. Liposome-based gene therapy
32. Efficacy of a peptide-based gene delivery system depends on mitotic activity
33. Human gene therapy
34. Polyethylenimine-mediated gene transfer into pancreatic tumor dissemination in the murine peritoneal cavity
35. Intracardiac echocardiographic guidance and monitoring during percutaneous endomycardial gene injection in porcine heart
36. Improved expression of vascular endothelial growth factor by naked DNA in mouse skeletal muscles implication for gene therapy of ischemic diseases
37. Ectopic expression of active processed form of atrial natriuretic peptide in skeletal myoblasts
38. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays
39. Physicochemical properties and in vitro toxicity of cationic liposome cDNA complexes